Search Results for "Eliquis Commercial Actors"

22:05 EDT 18th October 2017 | BioPortfolio

Matching Channels


The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and ...

Interleukin 6 IL 6 Receptor IL 6R

Although the causes of rheumatoid arthritis are not fully understood, constitutive overproduction of interleukin-6 (IL-6), a multifunctional cytokine that regulates immune response, inflammatory react...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Hepatitis B Immune Globulin Cangene

HepaGam B® [Hepatitis B Immune Globulin (Human) Injection] contains purified antibodies specific for the hepatitis B surface antigen (HBsAg). * It is approved in Canada and the United States f...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Matching News

Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

Audience: Cardiology, Pharmacy ISSUE: Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the ...

Bristol-Myers Squibb recalls mislabeled Eliquis medications

One lot of the blood thinner Eliquis distributed nationwide included bottles with 2.5 mg tablets, mislabeled as Eliquis 5 mg.

Bristol-Myers Squibb Pulls One Lot of Apixaban Over Tablet Mix-up

The voluntary measure was prompted after a consumer complained their bottle of Eliquis 5 mg contained Eliquis 2.5-mg tablets. News Alerts

Bristol-Myers recalls one lot of Eliquis over possible mislabeling

Bristol-Myers Squibb voluntarily recalls a single lot of blood thinner Eliquis that was distributed to wholesalers and retail pharmacies in February.

B-MS recalls US Eliquis Lot after low dose pills found in 5mg bottle

Bristol Myers Squibb (B-MS) has recalled one lot of the oral anti-clotting drug Eliquis in the US after a customer found 2.5mg strength tablets in a bottle labelled as containing 5mg tablets.

Bristol-Myers Squibb Recalls Lot of Eliquis Due to Dosage Mislabeling

NewsBristol-Myers Squibb voluntarily recalls one lot of Eliquis (apixaban) 5 mg tablets.

Transgender Actors School Med Students in Appropriate Care

Transgender actors can help residents learn to provide better, more sensitive care to transgender patients. Medscape Medical News

Crackdown On Bad Regenerative Medicine Actors By US FDA Could Benefit Honest Developers

The agency plans to offer a series of guidance documents on regenerative product development as enforcement against "unscrupulous actors" continues.   

Matching PubMed Articles

Action-effect sharing induces task-set sharing in joint task switching.

A central issue in the study of joint task performance has been one of whether co-acting individuals perform their partner's part of the task as if it were their own. The present study addressed this ...

Statistical learning in social action contexts.

Sensitivity to the regularities and structure contained within sequential, goal-directed actions is an important building block for generating expectations about the actions we observe. Until now, res...

Food Safety Perceptions and Practices among Smallholder Pork Value Chain Actors in Hung Yen Province, Vietnam.

Pork safety is an important public health concern in Vietnam and is a shared responsibility among many actors along the pork value chain. We examined the knowledge, perceptions, and practices regardin...

Infectious Disease Outbreak Response: Mind the Rights Gap.

The international organization responsible for international coordinated response to disease outbreaks-the World Health Organization (WHO)-was given permission to receive reports from informants other...

Comparison of Self-Identified Minor Attracted Persons who have and have not Successfully Refrained from Sexual Activity with Children.

The present study compares community-based minor attracted persons (MAPs) with and without histories of sexual activity with children. MAP-Actors (N = 342) were significantly older than Non-Actors (N ...

Search Whole site using Google

Quick Search
Advertisement Advertisement